MTOR and prostate carcinoma: AR signaling also impacts the cellular metabolism reprogramming observed in prostate cancer via binding, together with mTOR, to regulatory regions of the sterol regulatory element-binding transcription factor 1 (SREBF1) gene, which leads to increased expression [144].